Abstract
An important way for anti-tumor drug development is using of molecular targets involved in the regulatory pathways during tumorogenesis. As it was found microRNAs (miRs) are active players in this processes. Manipulations with miR-34a and onco-miR-21 demonstrated their effectiveness as antitumor intervention in glioblastoma (GBM), so stable and efficient nanocarriers should be found. One of the promising approach is using of dendrimers – highly symmetrical hyperbranched polymers. The aim of our study was evaluation of effects of treatment by complexes of dendrimers with miRs on human glioblastoma stem-like cells (GSCs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
